Faced with endless potential use cases, Datycs' CEO reveals their prioritization strategy: they wait for a new feature request, such as for social determinants of health, to mature and be echoed by two or three other customers before investing significant resources in building it.

Traditional API integration requires strict adherence to a predefined contract. The new AI paradigm flips this: developers can describe their desired data format in a manifest file, and the AI handles the translation, dramatically lowering integration barriers and complexity.

A company can build a significant competitive advantage in healthcare by deliberately *not* touching or seeing Protected Health Information (PHI). Focusing exclusively on metadata reduces regulatory overhead and security risks, allowing the business to solve the critical problem of data orchestration and intelligence, a layer often neglected by data aggregators.

Despite processing 15 million clinical charts, Datycs doesn't use this data for model training. Their agreements explicitly respect that data belongs to the patient and the client—an ethical choice that prevents them from building large, aggregated language models from customer data.

The next evolution in personalized medicine will be interoperability between personal and clinical AIs. A patient's AI, rich with daily context, will interface with their doctor's AI, trained on clinical data, to create a shared understanding before the human consultation begins.

Datycs' initial product, a patient chart summarizer for physicians, faced slow adoption from health systems. The company found a more viable business model by pivoting to solve an urgent problem for payers: processing massive volumes of unstructured documents for back-office operations.

Hospitals are adopting a phased approach to AI. They start with commercially ready, low-risk, non-clinical applications like RCM. This allows them to build an internal 'AI muscle'—developing frameworks and expertise—before expanding into more sensitive, higher-stakes areas like patient engagement and clinical decision support.

Before deploying AI across a business, companies must first harmonize data definitions, especially after mergers. When different units call a "raw lead" something different, AI models cannot function reliably. This foundational data work is a critical prerequisite for moving beyond proofs-of-concept to scalable AI solutions.

CEO Srini Rawl explains that while many companies focused on structured healthcare data, Datycs targeted complex, unstructured documents. This challenging niche became their competitive advantage, creating a significant data and experience moat after processing over 15 million clinical charts.